[Is regression of coronary sclerosis possible?]

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Preventive Cardiology

Context:

• Coronary artery disease (CAD) progression and regression are key indicators of cardiovascular health.
• Sequential coronary arteriography provides objective measures of lesion changes.
• Lipid management and lifestyle modifications are central to CAD treatment strategies.

Purpose:

• To evaluate the impact of aggressive lipid-lowering therapy and lifestyle changes on coronary artery lesions.
• To determine the relationship between achieved cholesterol and LDL cholesterol levels and lesion modification.
• To assess the effect of specific calcium channel blockers (nifedipine, nicardipine) on stenosis development.

Summary:

• Randomized studies demonstrate that aggressive lipid-lowering therapy and lifestyle changes can reduce the progression and induce modest regression of coronary artery lesions.
• The degree of lesion change is directly related to the achieved levels of cholesterol and low-density lipoprotein (LDL) cholesterol.
• Three studies confirmed that lipid-lowering interventions not only improve arteriographic lesions but also decrease clinical events.
• Calcium blockers like nifedipine and nicardipine do not affect lesion progression or regression but reduce the formation of new coronary stenoses.

Impact:

• Aggressive lipid management and lifestyle interventions are effective in modifying coronary atherosclerosis.
• Achieving lower cholesterol and LDL cholesterol targets is crucial for regression of coronary lesions.
• These findings support the use of lipid-lowering therapies to reduce both arteriographic disease burden and clinical cardiovascular events.
• Specific calcium channel blockers may play a role in preventing the development of new coronary artery blockages.